Bravecto Plus Topical Solution for Cats

Bravecto
Item #5316905

Bravecto Plus Topical Solution for Cats

Bravecto
Item #5316905
Prescription item
Fulfilled by VetSource
$52.99
Sign In & Enjoy Free Shipping Over $49
Prescription info required
About this item
Active Ingredients: Fluralaner, Moxidectin

Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. BRAVECTO PLUS Topical Solution for Cats should be applied topically as directed by your veterinarian. Manufacturer Dosage and Administration: Bravecto Plus Topical Solution should be administered topically as a single dose every 2 months according to your cat's body weight to provide a minimum dose of 18.2 mg⁄lb (40 mg⁄kg) fluralaner and 0.9 mg⁄lb (2 mg⁄kg) moxidectin. For prevention of heartworm disease, Bravecto Plus should be administered at 2–month intervals. Bravecto Plus may be administered year–round without interruption or at a minimum should be administered at 2–month intervals beginning at the cat's first seasonal exposure to mosquitoes and continuing until the cat's last seasonal exposure to mosquitoes. If a dose is missed and a 2–month interval between doses is exceeded, administer Bravecto Plus immediately and resume the dosing every 2 months. When replacing a monthly heartworm preventative product, the first dose of Bravecto Plus should be given within one month of the last dose of the former medication. A veterinarian or veterinary technician should demonstrate or instruct the pet owner regarding the appropriate technique for applying Bravecto Plus topically to cats prior to first use. Step 1: Immediately before use, open the pouch and remove the tube. Put on gloves. Hold the tube at the crimped end with the cap in an upright position (tip up). The cap should be rotated clockwise or counterclockwise one full turn. The cap is designed to stay on the tube for dosing and should not be removed. The tube is open and ready for application when a breaking of the seal is felt. Step 2: The cat should be standing or lying with its back horizontal during application. Part the fur at the administration site. Place the tube tip vertically against the skin at the base of the skull of the cat. Step 3: Squeeze the tube and gently apply the entire contents of Bravecto Plus directly to the skin at the base of the skull of the cat. Avoid applying an excessive amount of solution that could cause some of the solution to run and drip off of the cat. If a second spot is needed to avoid runoff, apply the second spot slightly behind the first spot. Greasy, oily, or wet appearance may occur at the application site in some cats.

Missed Doses: If a dose is missed: apply BRAVECTO PLUS Topical Solution as soon as you remember, then wait for the full prescribed dosing interval prior to administering the next dose. Do not apply two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian.

Side Effects: BRAVECTO PLUS Topical Solution is generally well tolerated. The most common side effects of this medication are application site reactions (e.g., hair loss, redness, dry skin, itching), generalized itching or hair loss (not at the application site), vomiting, diarrhea, decreased appetite, itching, hypersalivation (drooling), and drowsiness⁄lethargy. Contact your veterinarian immediately if your pet experiences severe or persistent vomiting, complete loss of appetite, has a seizure or any other neurologic adverse reaction (e.g., tremors, loss of coordination, weakness), or if you notice swelling of the chin, lips, or the area around the eyes. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian.

Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. For topical use on cats only– avoid oral ingestion. Not for human use. Keep this and all drugs out of the reach of children. Do not contact or allow children to contact the application site until 2 hours post–application. Keep the product in the original packaging until use to prevent children from getting direct access to the product. Do not eat, drink, o

From the manufacturer